Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.
OBJECTIVE
Considerable pilot data and clinical experience suggested that an aloe vera gel might help to prevent radiation therapy-induced dermatitis.


METHODS
Two Phase III randomized trials were conducted. The first one was double blinded, utilized a placebo gel, and involved 194 women receiving breast or chest wall irradiation. The second trial randomized 108 such patients to aloe vera gel vs. no treatment. Skin dermatitis was scored weekly during both trials both by patients and by health care providers.


RESULTS
Skin dermatitis scores were virtually identical on both treatment arms during both of the trials. The only toxicity from the gel was rare contact dermatitis.


CONCLUSIONS
This dose and schedule of an aloe vera gel does not protect against radiation therapy-induced dermatitis.
Toledo Community Clinical Oncology Program, OH, USA.
M S
MS
Williams
M
M
Burk
C L
CL
Loprinzi
M
M
Hill
P J
PJ
Schomberg
K
K
Nearhood
J R
JR
O'Fallon
J A
JA
Laurie
T G
TG
Shanahan
R L
RL
Moore
R E
RE
Urias
R R
RR
Kuske
R E
RE
Engel
W D
WD
Eggleston
D000328:Adult; D000368:Aged; D000504:Aloe; D001943:Breast Neoplasms / Q000532:radiotherapy*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D005782:Gels; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D010946:Plants, Medicinal; D011837:Radiation-Protective Agents / Q000008:administration & dosage*; D011855:Radiodermatitis / Q000517:prevention & control*; D012720:Severity of Illness Index
D003879:Dermatologic Agents; D005782:Gels; D010919:Placebos; D011837:Radiation-Protective Agents